Seminars in Hematology
Volume 44, Issue 3 , Pages 157-165, July 2007

Risks and Benefits of Erythropoiesis-Stimulating Agents in Cancer Management

  • Gernot Beutel

      Affiliations

    • Corresponding Author InformationAddress correspondence to Gernot Beutel, MD, Department of Hematology, Hemostasis, and Oncology, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany.
  • ,
  • Arnold Ganser

Department of Hematology, Hemostasis, and Oncology, Hannover Medical School, Hannover, Germany.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00067-4

doi:10.1053/j.seminhematol.2007.04.004

Seminars in Hematology
Volume 44, Issue 3 , Pages 157-165, July 2007